These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28094597)

  • 1. Comment On: Maintenance of Remission in Inflammatory Bowel Disease Using Omega-3 Fatty Acids (Fish Oil): A Systematic Review and Meta-Analyses.
    Mullin GE
    Nutr Clin Pract; 2011 Apr; 26(2):202-203. PubMed ID: 28094597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses.
    Turner D; Shah PS; Steinhart AH; Zlotkin S; Griffiths AM
    Inflamm Bowel Dis; 2011 Jan; 17(1):336-45. PubMed ID: 20564531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease.
    Turner D; Zlotkin SH; Shah PS; Griffiths AM
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006320. PubMed ID: 19160277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease.
    Lev-Tzion R; Griffiths AM; Leder O; Turner D
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD006320. PubMed ID: 24585498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease.
    Turner D; Zlotkin SH; Shah PS; Griffiths AM
    Cochrane Database Syst Rev; 2007 Apr; (2):CD006320. PubMed ID: 17443620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis.
    Turner D; Steinhart AH; Griffiths AM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006443. PubMed ID: 17636844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
    Chen M; Feng Y; Liu W
    Ann Palliat Med; 2021 Nov; 10(11):11821-11829. PubMed ID: 34872306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
    Ford AC; Bernstein CN; Khan KJ; Abreu MT; Marshall JK; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):590-9; quiz 600. PubMed ID: 21407179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
    Ford AC; Sandborn WJ; Khan KJ; Hanauer SB; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):644-59, quiz 660. PubMed ID: 21407183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics for maintenance of remission in Crohn's disease.
    Rolfe VE; Fortun PJ; Hawkey CJ; Bath-Hextall F
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004826. PubMed ID: 17054217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease.
    Yang C; Singh P; Singh H; Le ML; El-Matary W
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1079-93. PubMed ID: 25858208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary intake of fish, n-3 polyunsaturated fatty acids, and risk of inflammatory bowel disease: a systematic review and meta-analysis of observational studies.
    Mozaffari H; Daneshzad E; Larijani B; Bellissimo N; Azadbakht L
    Eur J Nutr; 2020 Feb; 59(1):1-17. PubMed ID: 30680455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.